Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $2.37 USD
Change Today -0.02 / -0.84%
Volume 785.0
TEAR On Other Exchanges
As of 9:46 AM 07/31/15 All times are local (Market data is delayed by at least 15 minutes).

tearlab corp (TEAR) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/4/14 - $4.69
52 Week Low
01/26/15 - $1.50
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for TEARLAB CORP (TEAR)

Related News

No related news articles were found.

tearlab corp (TEAR) Related Businessweek News

No Related Businessweek News Found

tearlab corp (TEAR) Details

TearLab Corp. operates as an ophthalmic device company in the United States. It develops and markets lab-on-a-chip technologies that enable eye care practitioners to enhance standard of care by objectively and quantitatively testing for disease markers in tears at the point-of-care. The company’s TearLab Osmolarity System is a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corp. was founded in 1996 and is headquartered in San Diego, California.

132 Employees
Last Reported Date: 03/13/15
Founded in 1996

tearlab corp (TEAR) Top Compensated Officers

Chairman, Chief Executive Officer and Secreta...
Total Annual Compensation: $326.9K
President and Chief Operating Officer
Total Annual Compensation: $370.0K
Vice President of Regulatory
Total Annual Compensation: $180.0K
Vice President of International Markets
Total Annual Compensation: $125.5K
Vice President of Medical Affairs
Total Annual Compensation: $84.6K
Compensation as of Fiscal Year 2014.

tearlab corp (TEAR) Key Developments

TearLab Corporation Announces Appointment of Wes Brazell as CFO

TearLab Corporation announced the appointment of Wes Brazell as its Chief Financial Officer, with overall responsibility for operational finance, financial reporting, budgeting and strategic planning, as well as helping to manage the company's relationships and interactions with the investment community. Mr. Brazell succeeds William Dumencu, who will continue to support the company in a consulting role until the end of 2015. He most recently served as the Chief Financial Officer of Academic Partnerships.

Mayer Hoffman McCann, P.C. Replaces Ernst & Young as TearLab Corporation's Independent Registered Public Accounting Firm for the Fiscal Year Ending December 31, 2015

Effective as of April 29, 2015, the Audit Committee of the Board of Directors of TearLab Corporation approved the appointment of Mayer Hoffman McCann, P.C. as the company's independent registered public accounting firm for the fiscal year ending December 31, 2015, commencing following the company's filing of its quarterly report on form 10-Q for the first fiscal quarter ending March 31, 2015. The company filed its quarterly report on May 8, 2015, at which time, Ernst & Young concluded its services as the company's independent registered public accounting firm. After the filing of the Quarterly Report on May 8, 2015, Mayer Hoffman McCann commenced its services as the company's independent registered public accounting firm.

TearLab Corporation Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

TearLab Corporation reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company reported revenues of $5,408,000 compared to $4,211,000 for the same period of last year. Loss from operations was $8,071,000 compared to $5,921,000 for the same period of last year. Net loss and comprehensive loss was $8,168,000 or $0.25 per diluted share compared to $5,557,000 or $0.17 per diluted share for the same period of last year.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEAR:US $2.37 USD -0.02

TEAR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for TEAR.
View Industry Companies

Industry Analysis


Industry Average

Valuation TEAR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book 4.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 2.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEARLAB CORP, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at